Buoyed by promising clinical findings, Moderna says it will explore alternatives for late-stage development of the H5 vaccine.
Most participants had more fatigue, loss of motivation, impaired concentration and attention, and worsened mood, and many reported more anxiety.
With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The drug's prevention efficacy was 76% in the 450-mg group, 61% in the 300-mg group, and 58% in the 150-mg group.
The results of 2 phase 2b trials suggest sutezolid and delpazolid could provide safer alternatives to linezolid in shorter drug regimens for drug-resistant TB.
Critics say the move will put patients at risk at a time when threats from emerging pathogens and antimicrobial resistance are on the rise.
The 2024-25 season was the highest severity flu season in more than a decade, according to a new analysis of US surveillance data.
The newly appointed work group leader has called mRNA vaccine dangerous and said they should be removed from the market.
Study shows vaccine effectiveness around 50% for both clinic visits and hospital stays for influenza during the 2025 Southern Hemisphere flu season.
Researchers say the findings highlight opportunities for further antibiotic stewardship interventions.
A second study suggests that long-COVID fatigue is linked to changes to the mitochondria in muscle cells.
Scientists have identified a novel antibiotic class that inhibits one of the building blocks of the tough outer membrane of the highly drug-resistant pathogen.
Safety concerns were more prevalent in higher income parents, while knowledge gaps and lack of provider recommendation were more common in their lower income peers.
The findings, the authors say, support the recommendation of COVID-19 vaccination for all children aged 6 months and older.
Catastrophic flooding in Pakistan last year led to a fivefold jump in cases.
A study of ambulatory antibiotic prescriptions in a large medical system found a higher proportion of prescriptions for not-in-person visits were inappropriate than those for in-person visits.
Pfizer announces positive findings of the investigational antibiotic combination aztreonam-avibactam.
The risk of hospitalization or death by 28 days was 4.6% among the 2,571 mAb recipients, compared with 7.6% among the 5,135 matched control patients (risk ratio, 0.61).
Infected women were more likely to need tracheostomy and ventilation and to have heart attack, sepsis, and blood clots.
The subvariant could spread globally and fuel increased cases, due its growth advantage and immune escape properties.
Rebound was uncommon after use of the oral antivirals Paxlovid and molnupiravir to lower the risk of severe outcomes.
In one large nursing home system, booster doses were 88% effective in preventing COVID-related deaths.
A Spanish study offers insight as to how and when semen may be able to transmit the virus, as well as viral shedding from lesions.
Relative to rates at 1 month after the first lockdown ended, stress, anxiety, and depression rose by 2.5%, 13.9%, and 22.2%, respectively, by 15 months.
The outbreak was announced on Sep 20, 2022, and involved 142 confirmed cases and a 39% case-fatality rate.
